ArticlePharmaceuticals (Basel, Switzerland)2020

Evaluation of Tissue and Circulating miR-21 as Potential Biomarker of Response to Chemoradiotherapy in Rectal Cancer.

Susana Ourô et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.